AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.
9 reports, 3 independent
Updated Jul 19
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 9
- Developments
- 6
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.AbbVie's recent spin-off from Abbott Laboratories and ongoing Humira patent loss.1 source
AbbVie's corporate roots trace back to Abbott Laboratories.1 source
Historical fact regarding the corporate split between AbbVie and Abbott Laboratories.1 source
Stock performance update for Abbott on September 3, 2025.1 source
AbbVie inherited Humira and faces patent challenges, linking its operations to its 2013 split from Abbott.1 source
- Abbott spun off AbbVie as a separate business.
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Abbott Laboratories
American global health care and medical device products company
Related events
- Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.
- Syndax Pharmaceuticals and AbbVie are competing in the healthcare and biopharma sector.
- Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.
- AbbVie, Abbott Laboratories, and Johnson & Johnson were recommended as dividend stocks for retirees, operating in the healthcare sector.
- AbbVie, AstraZeneca, and GSK are major players in global drug development, facing challenges in the drug class and pursuing licensing deals with Chinese biotechs.
Coverage
Newest first; wire copies grouped- fool.com
- fool.com
- fool.com
- Motley FoolCould These 3 Dividend Kings Be Worth $1 Trillion in 10 Years? AbbVie, Johnson & Johnson, and Abbott Laboratories have impeccable dividend programs. All three are among the largest healthcare compani
- ZacksHere is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider som
- Motley Fool2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer AbbVie is a Dividend King that should hold onto its crown for years to come. Verizon offers an ultra-high yield and is po
- Motley FoolIf You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today AbbVie has performed better than the market over the past decade. The company has lost a major product, but its
- Motley FoolGot $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever AbbVie has continually innovated to stay ahead of the competition. Bristol Myers Squibb's business is going through changes, but it has a
- Unknown outlet